Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 study is being conducted to evaluate the efficacy and safety of Omega-3-acids Ethylesters 90 in patients with hyperlipidemia, including familial combi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Combined Hyperlipidemia
• Hyperlipidemia

Drugs mentioned

• Omega-3-acids Ethylesters 90 (Omega-3-acid ethyl esters 90)

Snippet

Sponsor: Kuhnil Pharmaceutical Co., Ltd. | Conditions: Hyperlipidemia, Familial Combined | Phase 3 | Status: UNKNOWN